Rocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders.
Rocket Pharmaceuticals has raised $165.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2024.
Rocket Pharmaceuticals's investors include RTW Investments, Frazier Healthcare Partners, Civilization Ventures, California Institute for Regenerative Medicine, Sahsen Ventures.
Rocket Pharmaceuticals is headquartered in Cranbury, United States.
Rocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders.
Rocket Pharmaceuticals is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Rocket Pharmaceuticals — Funding & Investors." VCBacked, December 11, 2024, https://www.vcbacked.co/company/rocket-pharmaceuticals. Accessed August 15, 2026.
VCBacked. (2024). Rocket Pharmaceuticals — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/rocket-pharmaceuticals
{{cite web |title=Rocket Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/rocket-pharmaceuticals |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated